semaglutide for bariatric patients Ozempic vs. Surgery Rise of Semaglutide: Novo Nordisk,

Weight loss medication shortage creates market for bogus drugs Novo Nordisk said it was steadily increasing capacity to produce more Wegovy though demand is still outpacing supply Counterfeit versions of weight-loss related medications are "detrimental to the field of obesity medicine" and can pose severe risks to patient health, particularly to those who rely on them most, according to medical experts

It enrolled 307 adults with obesity or who were overweight who also had at least 1 weight-related health condition

Patients navigating this space need to hold three regulatory categories simultaneously: FDA-approved compounds (semaglutide, tirzepatide, tesamorelin) with defined safety profiles from Phase III trials

Aim for water or electrolyte-enhanced fluids rather than sugary or carbonated drinks, which can worsen GI symptoms

PMID: 34345678 Martinez, A., et al

No, per FDA 2024 recommendations